πŸ‡ΊπŸ‡Έ FDA
Patent

US 6686362

Indolinone derivatives

expired A61PA61P35/00A61P35/02

Quick answer

US patent 6686362 (Indolinone derivatives) held by Theravance, Inc. expires Mon Jan 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue Feb 03 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61P, A61P35/00, A61P35/02, A61P43/00, A61P9/08